The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.

Tuberous sclerosis is an autosomal dominant trait in which the dysregulation of cellular proliferation and differentiation results in the development of hamartomatous growths in many organs. The TSC2 gene is one of two genes determining tuberous sclerosis. Inactivating germline mutations of TSC2 in patients with tuberous sclerosis and somatic loss of heterozygosity at the TSC2 locus in the associated hamartomas indicate that TSC2 functions as a tumour suppressor gene and that loss of function is critical to expression of the tuberous sclerosis phenotype. The TSC2 product, tuberin, has a region of homology with the GTPase activating protein rap1GAP and stimulates the GTPase activity of rap1a and rab5a in vitro. Here we show that the region of homology between tuberin and human rap1GAP and the murine GAP mSpa1 is more extensive than previously reported and spans approximately 160 amino acid residues encoded within exons 34-38 of the TSC2 gene. Single strand conformation polymorphism analysis of these exons in 173 unrelated patients with tuberous sclerosis and direct sequencing of variant conformers together with study of additional family members enabled characterisation of disease associated mutations in 14 cases. Missense mutations, which occurred in exons 36, 37 and 38 were identified in eight cases, four of whom shared the same recurrent change P1675L. Each of the five different missense mutations identified was shown to occur de novo in at least one sporadic case of tuberous sclerosis. The high proportion of missense mutations detected in the region of the TSC2 gene encoding the GAP-related domain supports its key role in the regulation of cellular growth.

[1]  J. Declue,et al.  Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY (*) , 1995, The Journal of Biological Chemistry.

[2]  K. S. Fuiks,et al.  Tuberous sclerosis (2nd ed.) , 1989 .

[3]  S. Smalley,et al.  Phenotypic variation of tuberous sclerosis in a single extended kindred. , 1994, Journal of medical genetics.

[4]  S. Verhoef,et al.  Identification of a nonsense mutation at the 5' end of the TSC2 gene in a family with a presumptive diagnosis of tuberous sclerosis complex. , 1996, Journal of medical genetics.

[5]  M. Pericak-Vance,et al.  A novel splice site mutation (156 + 1G→A) in the TSC2 gene , 1997, Human mutation.

[6]  M. Short,et al.  Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. , 1996, Human molecular genetics.

[7]  J. Attwood,et al.  Two loci for Tuberous Sclerosis: one on 9q34 and one on 16p13 , 1994, Annals of human genetics.

[8]  F. McCormick,et al.  Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21 rap1 , 1991, Cell.

[9]  M. Delgado,et al.  Mutations and polymorphisms in the tuberous sclerosis complex gene on chromosome 16 , 1997, Human mutation.

[10]  D. Lipman,et al.  Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Sandford,et al.  Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish. , 1996, Human Molecular Genetics.

[12]  M. Lerman,et al.  Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. , 1994, Human molecular genetics.

[13]  E. Golemis,et al.  The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis* , 1997, The Journal of Biological Chemistry.

[14]  J. Hughes,et al.  Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndrome , 1994, Nature Genetics.

[15]  Mark S. Boguski,et al.  Proteins regulating Ras and its relatives , 1993, Nature.

[16]  B. Scheithauer,et al.  Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. , 1996, American journal of human genetics.

[17]  M. Pericak-Vance,et al.  A de novo frame-shift mutation in the tuberin gene. , 1995, Human molecular genetics.

[18]  S. Thomas,et al.  Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.

[19]  T. Sepp,et al.  Loss of heterozygosity in tuberous sclerosis hamartomas. , 1996, Journal of medical genetics.

[20]  A. Ouweland,et al.  Somatic mosaicism and clinical variation in tuberous sclerosis complex , 1995, The Lancet.

[21]  A. Green,et al.  Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients , 1994, Nature Genetics.

[22]  D. Kwiatkowski,et al.  Tuberous sclerosis. , 1994, Archives of dermatology.

[23]  J B Stephenson,et al.  Genetic aspects of tuberous sclerosis in the west of Scotland. , 1989, Journal of medical genetics.

[24]  P. Huttenlocher,et al.  Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association , 1992 .

[25]  T. Kobayashi,et al.  cDNA structure, alternative splicing and exon-intron organization of the predisposing tuberous sclerosis (Tsc2) gene of the Eker rat model. , 1995, Nucleic acids research.